Itonis, Inc. announces planned update on 10,000 commercial spots for Emesyl anti-nausea relief

Posted 11:23:00 04/13/2016 by Admin

LAGUNA HILLS, CA – (April 13, 2016) - Itonis, Inc. (OTC PINKSHEETS: ITNS)

Itonis is pleased to announce that it will begin airing its planned Ten Thousand (10,000) thirty (30) second commercial spots for its Emesyl product upon delivery of its first batch of product from National Homeopathic Labs.

A previously signed agreement to provide marketing and public relations services for its Emesyl product calls for placing the 10,000 commercial spots in select regional areas on the most popular cable television networks available. The networks available to Itonis for airing selection choice include ESPN, CNN, Fox News, Discovery Channel, SPIKE, AMC, TBS, Lifetime, A&E, Comedy Central, TV Land, Nickelodeon, Travel Channel, ESPN2, USA, HLN, BET, MTV, SyFy, CMT, TLC, TNT, and FX, etc., and have the ability to air more frequently in any of these select networks.

“The closing of Oasis Health Products forced us to put a hold on this commercial launch until we could secure additional product, and now our new relationship with National Homeopathic Labs allows us to move forward as planned. We’re extremely excited that our Emesyl commercials will finally become a reality,” said Steve Pidliskey, Itonis Vice President.

About Itonis, Inc.

Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industries. The company also holds a licensing agreement with MyECheck Inc, which allows the company to use MyECheck’s patented mobile payment application and share transaction revenue fees for point of purchase payments across various industries. Please visit www.itonisholdings.com for additional information.

About National Homeopathic Labs.

Located in Las Vegas, Nevada, the company is a cGMP, FDA registered contract manufacturer that specializes in formula development and packaging of homeopathic, nutritional, cosmeceutal, and dietary supplements.


Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:
Itonis, Inc.
Office@itonisholdings.com